CCM
OGN icon

CAAS Capital Management’s Organon & Co OGN Stock Holding History

CAAS Capital Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,400
Closed -$150K – 615
2023
Q4 		$150K Buy
+10,400
New +$141K 0.02% 369
2021
Q4 		– Sell
-526,001
Closed -$17.2M – 991
2021
Q3 		$17.2M Buy
526,001
+446,638
+563% +$14.3M 0.35% 62
2021
Q2 		$2.4M Buy
+79,363
New +$2.61M 0.04% 362

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CAAS Capital Management's OGN Position: Q1 2024 in Review

CAAS Capital Management sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 10,400 shares — an estimated $150K sold.

CAAS Capital Management first reported a position in OGN in Q2 2021 and held it in 3 quarters. The position peaked at $17.2M in Q3 2021. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • CAAS Capital Management reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
  • CAAS Capital Management sold 10,400 Organon & Co shares in Q1 2024, an estimated $150K.
  • CAAS Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 3 quarters.
  • CAAS Capital Management's Organon & Co position peaked at $17.2M in Q3 2021.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on CAAS Capital Management's 13F filing for Q1 2024, filed 26 Apr 2024.